Table: Kaken Pharmaceutical - 9-MTH group results

KAKEN PHARMACEUTICAL

03/02/2020 04:30

Feb 3 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2019        Dec 31, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             70.18               72.58            92.90    
                 (-3.3 pct)          (-5.6 pct)       (-1.3 pct)  
  Operating         22.43               19.90            22.30    
                 (+12.7 pct)         (-16.0 pct)      (-9.3 pct)  
  Recurring         22.83               20.25            22.70    
                 (+12.7 pct)         (-15.8 pct)      (-9.1 pct)  
  Net               15.55               14.25            16.10    
                 (+9.2 pct)          (-15.5 pct)      (-9.4 pct)  
  EPS            396.67 yen          356.84 yen       413.70 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div         75.00 yen           75.00 yen                   
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T